Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/185548
Title: | Higher mortality and intubation rate in COVID-19 patients treated with noninvasive ventilation compared with high-flow oxygen or CPAP |
Author: | Marti, Sergi Carsin, Anne Elie Sampol, Júlia Pallero, Mercedes Aldas, Irene Marin, Toni Lujan, Manel Lalmolda, Cristina Sabater, Gladis Bonnin Vilaplana, Marc Peñacoba, Patricia Martinez Llorens, Juana Tárrega, Julia Bernadich, Óscar Córdoba Izquierdo, Ana Lozano, Lourdes Mendez, Susana Vélez Segovia, Eduardo Prina, Elena Eizaguirre, Saioa Balañá Corberó, Ana Ferrer, Jaume Garcia Aymerich, Judith |
Keywords: | COVID-19 Insuficiència respiratòria COVID-19 Respiratory insufficiency |
Issue Date: | 20-Apr-2022 |
Publisher: | Springer |
Abstract: | The effectiveness of noninvasive respiratory support in severe COVID-19 patients is still controversial. We aimed to compare the outcome of patients with COVID-19 pneumonia and hypoxemic respiratory failure treated with high-flow oxygen administered via nasal cannula (HFNC), continuous positive airway pressure (CPAP) or noninvasive ventilation (NIV), initiated outside the intensive care unit (ICU) in 10 university hospitals in Catalonia, Spain. We recruited 367 consecutive patients aged >= 18 years who were treated with HFNC (155, 42.2%), CPAP (133, 36.2%) or NIV (79, 21.5%). The main outcome was intubation or death at 28 days after respiratory support initiation. After adjusting for relevant covariates and taking patients treated with HFNC as reference, treatment with NIV showed a higher risk of intubation or death (hazard ratio 2.01; 95% confidence interval 1.32-3.08), while treatment with CPAP did not show differences (0.97; 0.63-1.50). In the context of the pandemic and outside the intensive care unit setting, noninvasive ventilation for the treatment of moderate to severe hypoxemic acute respiratory failure secondary to COVID-19 resulted in higher mortality or intubation rate at 28 days than high-flow oxygen or CPAP. This finding may help physicians to choose the best noninvasive respiratory support treatment in these patients. Clinicaltrials.gov identifier: NCT04668196. |
Note: | Reproducció del document publicat a: https://doi.org/10.1038/s41598-022-10475-7 |
It is part of: | Scientific Reports, 2022, vol. 12, num. 1 |
URI: | http://hdl.handle.net/2445/185548 |
Related resource: | https://doi.org/10.1038/s41598-022-10475-7 |
ISSN: | 2045-2322 |
Appears in Collections: | Articles publicats en revistes (ISGlobal) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
s41598-022-10475-7.pdf | 1.08 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License